McKee Amy E - Insider Non-Derivative Transactions at BIOCRYST PHARMACEUTICALS INC (BCRX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 28, 2025, McKee Amy E's relationship to BIOCRYST PHARMACEUTICALS INC (BCRX) is Director, and currently has 41,790 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BCRX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

McKee Amy E - Insider Non-Derivative Transactions of BCRX Common Stock

McKee Amy E - Insider Non-Derivative Transactions at BCRX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 29, 2025	Acquisition -- (Common Stock)	783	7.18	41790
Aug 30, 2025	Acquisition -- (Common Stock)	676	8.31	41007
Jun 13, 2025	Acquisition -- (Common Stock)	12500	0	40331
Jun 25, 2024	Sell -- (Common Stock)	8600	6.32	27831
Jun 13, 2024	Acquisition -- (Common Stock)	6820	0	36431
Jun 14, 2023	Acquisition -- (Common Stock)	16745	0	29611